FDA Inspection 1068887 — Oklahoma Blood Institute Southwest
The FDA completed an inspection of Oklahoma Blood Institute Southwest on Jul 26, 2018 in Lawton, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 26, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lawton, OK (United States)